SyntekaBio Extends DeepMathcer Service Contract with LudaCure by 1 Month, Conditional Structure Remains
SyntekaBio corrected the end date of its single sales and supply contract for 'DeepMathcer service' with LudaCure from May 31, 2026 to June 30, 2026, extending the contract by one month.
Total contract value is KRW 400 million (excl. VAT), a conditional contract with no fixed amount. This represents 324.13% of 2023 separate revenue of KRW 123.41 million.
Conditional payment milestones: Success-linked I (KRW 150 million upon delivery of 6 CNR1 active substances), Success-linked II (KRW 250 million upon delivery of 1 CNR1 candidate). Revenue recognition only upon milestone achievement.
The extension provides an additional month to meet conditions, but the conditional structure remains unchanged, making near-term revenue contribution uncertain. No dilution or capital change for existing shareholders.
[AI Comprehensive Analysis]This filing is a routine contract extension with limited direct impact on enterprise value. Given the conditional nature, actual revenue recognition remains the key determinant of stock performance; investors should monitor milestone progress closely.
KOSDAQ Filing Information
Filing: [Correction of Description] Conclusion of Single Sale and Supply Contract